Coronary heart disease (CHD) is a complex genetic disease involving gene-environment interaction. Many association studies between single nucleotide polymorphisms (SNPs) of candidate genes and CHD have been reported. We have applied a new method to analyze such relationships using support vector machines (SVMs), which is one of the methods for artificial neuronal network. We assumed that common haplotype implicit in genotypes will differ between cases and controls, and that this will allow SVM-derived patterns to be classifiable according to subject genotypes. Fourteen SNPs of ten candidate genes in 86 CHD patients and 119 controls were investigated. Genotypes were transformed to a numerical vector by giving scores based on difference between the genotypes of each subject and the reference genotypes, which represent the healthy normal population. Overall classification accuracy by SVMs was 64.4% with a receiver operating characteristic (ROC) area of 0.639. By conventional analysis using the 2 test, the association between CHD and the SNP of the scavenger receptor B1 gene was most significant in terms of allele frequencies in cases vs. controls (p = 0.0001). In conclusion, we suggest that the application of SVMs for association studies of SNPs in candidate genes shows considerable promise and that further work could be usefully performed upon the estimation of CHD susceptibility in individuals of high risk. Clin Chem Lab Med 2003; 41(4): 529 -534
Introduction
Coronary heart disease (CHD) is the leading cause of death in developed countries (1) . CHD is the complex genetic disease involving many genes, environmental influences, and important gene-environment interactions (2) . CHD patients show varying clinical and angiographic features and that the importance of the different pathogenetic components may be different in different patients (3) . Prevention of CHD is made difficult not only by the multiple predisposing causes of CHD but also by the individual's susceptibility to these causes. Emerging evidence suggests that common variations in genes, called single nucleotide polymorphisms (SNPs), are associated with CHD and can modulate the effect of environmental risk factors on the development of CHD (4) . However, the identification of SNPs in genes associated with complex disease including CHD is often very difficult because their individual contributions are likely to be small (5) . Therefore, we not only analyzed the association between a single SNP and CHD using the χ 2 test for allele frequency in cases and controls but also estimated the combinational effects of multiple SNPs in attempt to detect CHD using support vector machines (SVMs).
SVMs (6, 7) have been successfully applied to a wide range of pattern recognition problems, including microarray gene expression data. SVMs can classify genes into some functional categories based on expression data obtained from a microarray and have allowed predictions to be made concerning the functions of unannotated yeast genes (8) . SVMs, which are based on a solid mathematical foundation, attempt to solve a universal problem of classification that we need to know which belongs to which group. Applied to multiple SNP data, the process of constructing SVMs begins with the transformation of genotypes of multiple SNPs of each individual into a numerical vector. Vectors are labeled positively if the individuals are in the CHD group and are labeled negatively if they are in the control group. Using this training set of SNP vectors, SVMs would learn to discriminate between the CHD and control group (9) . Having learned the vector features of the class, SVMs can recognize a new individual as a member of the CHD group or of the control group based on their SNP data. Moreover, the SVMs could also be retrained to identify outliers that may have previously been assigned to the incorrect class in the training set. Then, SVMs would use the information in the training set to determine what SNP features are characteristic of a given CHD or control group, and use this information to decide whether any *E-mail of the corresponding author: jqkim@plaza.snu.ac.kr
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given SNP data are likely belong to a CHD or control group.
We describe here not only the use of χ 2 statistics to determine the association between a single SNP and CHD but also the use of SVMs to classify subjects as members of the CHD or of the control group based on a set of multiple SNP data. We genotyped 14 SNPs on 10 candidate genes related to CHD risk in 86 CHD patients and 119 age-matched healthy controls.
Materials and Methods

Study subjects and samples
Eighty-six patients (54 males and 32 females) with CHD, as documented by coronary angiography because of recent myocardial infarction or angina, were selected at Seoul National University Hospital. The normal control group consisted of 119 age-matched individuals (63 males and 56 females) who were selected by health-screening at the same hospital in order to exclude those with a history of chest pain, diabetes, hypertension, and general illnesses. Blood samples were placed into EDTA tubes and stored at -70°C until assay.
Lipid and apolipoprotein analysis
The concentrations of plasma cholesterol and triglycerides were determined using enzymatic methods (Roche Diagnostics, Mannheim, Germany). High density lipoprotein-cholesterol (HDL-C) was measured directly with HDL-C diagnostic kits (Kyowa Medex, Tokyo, Japan) using a Hitachi 747 automatic chemistry analyzer. The level of low density lipoproteincholesterol (LDL-C) was calculated using the formula of Friedwald et al. (10) , and the levels of apolipoprotein (apo)A-I and apoB were measured by immunonephelometric assay (Bering Nephelometer, Beringwerke AG, Germany). Lipoprotein(a) (Lp(a)) was measured using commercially available enzymelinked immunosorbent assay kit (IMMUNO GmbH, Heidelberg, Germany). Body mass index (BMI) was calculated by dividing weight by (height) 2 .
Selection of candidate genes
We selected 10 genes probably related to CHD, based on encoded molecules that have roles in thrombosis, thrombolysis, vasodilator tone, and lipid metabolism. The ten genes were: apoCIII, apoE, lipoprotein lipase, scavenger receptor B1 (SRB1), lipoprotein receptor-related protein, factor VII, plasminogen activator inhibitor 1 (PAI-1), glycoprotein 1b α-polypeptide (GP1BA), superoxide dismutase (SOD), and the endothelial nitric oxide synthase (eNOS) genes. The accession number of appropriate the GeneBank reference sequences, the location of the sequences, and the bases potentially substituted in the 14 SNPs and the dbSNP numbers are summarized in Table 1 .
Genotyping SNPs
DNA samples were extracted from peripheral blood by standard methods. Genomic DNA was subjected to PCR and the identity of the PCR products were confirmed by digestion with a restriction enzyme and subsequent agarose electrophoresis. Fourteen pairs of oligomers were chosen to serve as PCR primers to amplify regions containing each of the SNPs in the 10 candidate genes. The nucleotide sequence of these primers, restriction enzymes, and the expected sizes of the PCR products are indicated in Table 2 .
Statistical analysis
Statistical analyses were performed with the Statistical Package for the Social Sciences (SPSS, SPSS Inc., Chicago, IL, USA), version 9.01 for Windows. Variables in two or three groups were compared using the Mann-Whitney U-test or the Kruskal-Wallis test. The χ 2 test and Fisher's exact test were used to test for independent relationships between variables. The difference of the allele frequencies of CHD patients and controls were evaluated using χ 2 test. The Hardy-Weinberg equilibrium of alleles at individual loci was assessed using χ 2 statistics. 
Support vector machines
When SVMs classify, they separate a given set of binary-labeled training data with a hyper-plane that is maximally distant from the point of each set. For cases in which no linear separation is possible, SVMs can work using kernel functions, which automatically realize a non-linear mapping to a feature space. The hyper-plane found by the SVM in feature space corresponds to a non-linear decision boundary in the input space. For a set of 14 SNPs in each individual, their representation as a vector in a Euclidean space is found as follows: The reference genotype at each SNP site can be selected by choosing the most common genotypes in the normal controls. By giving scores based on difference between the genotypes of the SNPs in each subject (CHD patients and controls) and the reference genotype, a vector of 14 dimensions was assigned to each individual. A set of n SNPs sites from m individuals was represented as a difference score matrix, in which each of the m rows consists of an n-element difference score vectors.
In our experiments, the number of individuals m was 203 and the number of difference scores n was 14. At each SNP location, we awarded difference score uniformly such as diff(w/w, w/w) = 1, diff(w/w, w/m) = 2. The corresponding decision function is ƒ(X) = sign{ W,φ(X) -b}. It is easy to prove that, for the maximal margin hyper-
, where α i are positive real numbers that
the decision function can equivalently be expressed as
possible to see that the α i associated with the training point X i expresses the strength with which that point is embedded in the final decision function. A remarkable property of this alternative representation is that often only a subset of the points will be associated with non-zero α i . These points are called support vectors and are the points that lie closest to the separating hyper-plane. The matrix
called the kernel matrix. In the case when the data are not linearly separable, one can use more general functions,
, that provide non-linear decision boundaries. For abbreviations: see Table 1 .
Two classical choices are polynomial kernels K(
and σ are kernel parameters. The experiments presented in this paper were performed using a freely available implementation of the SVM classifier which can be obtained at http://www.cs.columbia.edu/~bgrundy/svm (8) .
Validation of SVM methods
The goal of SVM is that a learning classifier should become trained well enough in terms of its teaching examples to be able to generalize new examples (actual error rate). The actual error rate of small data numbers was determined by hold-one-out cross validation (11) . The SVM is trained using data from all but one of the subjects. The vector of subject not used in training is then assigned a class by the SVM. A single SVM experiment consists of a series of hold-one-out experiments, the vector of each subject being held out and tested exactly once (11) . A receiver operating characteristic (ROC) curve was constructed for each of the SVM methods, and the area under the ROC curve quantified the diagnostic accuracy of a test as a single number, with 1 indicating perfect discrimination and 0.5 signifying discrimination no better than random assignment (12) .
Results
Conventional analysis for the association between single SNP and CHD
Demographic features and risk factor status among subjects are summarized in Table 3 . No significant difference was found between the age and sex distribution of the CHD patients and controls. The levels of BMI, cholesterol, HDL-C, LDL-C, and apoAI showed significant differences between the CHD patients and controls. Allele and genotype frequencies of SNPs in candidate genes are shown in Table 4 . An association between CHD and the SNP at SRB1 gene was statistically significant in terms of allele frequency comparisons in CHD patients vs. the controls (p = 0.0001). However, no significant difference was found between the allele frequencies of the other SNPs in the CHD patients and controls. Table 5 summarizes the results of a hold-one-out crossvalidation experiment using all four SMV methods. Performance was evaluated for each method and was involved allocating a positive or negative classification label for each member of the test set based only on what it has learned from the training set. The first four columns are the categories false positive (FP), false negative (FN), true positive (TP), and true negative (TN), and the fifth is a measure of overall accuracy. No significant difference in accuracy and in ROC areas was observed for the different SVM methods.
SVM analysis for the association between multiple SNPs and CHD
Discussion
It is estimated that 90% of naturally occurring sequence variations are SNPs, which can be small enough to manifest detectable linkage disequilibrium in human population (13) . Mutations, which have recently been introduced into a population, tend to demonstrate linkage disequilibrium with nearby polymorphisms. Detecting association between these SNPs and disease may provide useful evidence for the existence of a susceptibility locus within such a region and can lead to the identification of the gene and of pathogenic polymorphisms. However, as SNPs are biallelic they have relatively little power in association studies compared with the information that could be obtained by using haplotypes. With regard to complex disease, such as CHD, each related gene contributes disease susceptibility to some extent, but such genes may also interact with each other. If different mutational events have occurred in a gene related to disease at different points in some population history, then the frequencies of both these haplotypes of mutations will be increased among cases. However, it is very difficult to detect these using conventional methods, when only the multilocus genotypes are available for study. Studying individual SNPs might be fail to detect association with disease because each allele might be associated with a different gene, which have opposing effects on disease development, the two thus tend to cancel each other and the result is little difference in the overall allele frequencies in comparisons between cases and controls (14) . Some association has been maintained through link- age disequilibrium, and particular haplotypes should be more commonly found on chromosomes bearing pathogenic mutations. Such haplotypes should act in a similar way to multiallelic markers, and should be better able to produce detectable associations, when there are multiple mutation events. Then, in association studies between multiple SNPs and complex disease, it is more efficient to use a marker haplotype rather than a single biallelic marker (5, 13) . Our results show that SVMs can provide a simple and practical method for dealing with a set of multiple SNP data as a marker haplotype, such is produced using marker haplotypes, which are obtained from standard case-control studies. SVMs can produce a discriminant function (hyper-plane function), which has the ability to classify sets of input values (difference score vectors) according to their output values (CHD patients and controls), so that a given set of input values will produce a set of outputs close to the observed values (6) . Standard methods are to adjust the SVM parameters (hyper-plane function) in order to produce output values, which approximate the target values. Sets of input data and target outputs are repeatedly presented to the SVMs and changes are made to mod- ify parameters of the hyper-plane function in a way which improves the overall performance of the SVMs. In terms of the association study between multiple SNPs and CHD, SVMs allow multiple SNP data to be analyzed simultaneously, even when haplotypes are unavailable. Such analyses complement conventional analyses based on single markers.
